DNA Primase Subunit 1 Expression in Hepatocellular Carcinoma and Its Clinical Implication

Table 2

The relationship between PRIM1 expression and clinical pathological characteristics (logistic regression).

Clinical characteristics	Total ()	Odds ratio	value
Sex (male vs. female)	360	0.97 (0.63-1.52)	0.910
BMI (<25 kg/m^2 vs. ≥25 kg/m^2)	327	0.65 (0.42-1.00)	0.053
Stage (I-II vs. III-IV)	336	1.75 (1.07-2.89)	0.026
Grade (G1-G2 vs. G3-G4)	355	2.27 (1.47-3.55)	<0.001
Age (<55 y vs. ≥55 y)	360	0.68 (0.43-1.06)	0.089
AFP (≤400 ng/ml vs. >400 ng/ml)	270	2.45 (1.37-4.49)	0.003
Platelet (10^3/mm^3)	295	1.00 (1.00-1.00)	0.434
Race (Asian vs. non-Asian)	350	0.83 (0.55-1.27)	0.396

Notes: BMI: body mass index; AFP: alpha-fetoprotein; PRIM1: DNA Primase Subunit 1.